Prof. dr. Anke van den Berg Klinisch moleculair bioloog in de pathologie

Wetenschappelijke publicaties

• Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers
• Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
• Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes